S

SILO

Silo Pharma Inc

0.64

0.03+4.08%
After Hours: 0.6206  -0.02  -3.48%19:57 06/25 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

7.41M

7.75M

11.64M

10.49M

1.43M

Total Current Assets

7.11M

7.68M

11.57M

10.40M

1.43M

Total Non Current Assets

300.36K

64.98K

70.82K

87.87K

0

Total Liabilities

2.38M

1.57M

1.30M

1.43M

145.97K

Total Current Liabilities

1.66M

775.59K

436.32K

490.04K

141.72K

Total Non Current Liabilities

721.58K

793.68K

865.78K

937.88K

4.25K

Total Equity

5.03M

6.18M

10.34M

9.06M

1.28M

Total Stockholders Equity

5.03M

6.18M

10.34M

9.06M

1.28M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

7.41M

7.75M

11.64M

10.49M

1.43M

Total Common Shares Outstanding

4.48M

2.91M

3.16M

1.97M

1.70M

Total Preferred Shares Outstanding

--

--

--

--

0